[KLK] YoY Quarter Result on 31-Mar-2011 [#2]

Stock
[KLK] KUALA LUMPUR KEPONG BHD
Announcement Date
25-May-2011
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2011
Quarter
31-Mar-2011 [#2]
Profit Trend
QoQ- 22.9%
YoY- 73.13%
Quarter Report
Latest QR
Upcoming QR
KLK's Result
KLK's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Revenue 2,934,043 2,235,550 2,624,204 2,368,357 1,901,301 1,438,560 1,895,549 7.54%
PBT 424,427 284,560 311,602 503,833 299,464 158,108 340,259 3.75%
Tax -87,299 -59,073 -80,964 -107,015 -71,246 -41,473 -89,560 -0.42%
NP 337,128 225,487 230,638 396,818 228,218 116,635 250,699 5.05%
-
NP to SH 314,605 209,657 214,908 373,854 215,938 112,681 236,655 4.85%
-
Tax Rate 20.57% 20.76% 25.98% 21.24% 23.79% 26.23% 26.32% -
Total Cost 2,596,915 2,010,063 2,393,566 1,971,539 1,673,083 1,321,925 1,644,850 7.90%
-
Net Worth 8,029,841 7,188,518 7,007,474 6,358,713 5,707,237 5,133,482 5,069,657 7.96%
Dividend
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Div 159,744 159,744 159,744 159,766 159,717 106,503 159,758 -0.00%
Div Payout % 50.78% 76.19% 74.33% 42.74% 73.96% 94.52% 67.51% -
Equity
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Net Worth 8,029,841 7,188,518 7,007,474 6,358,713 5,707,237 5,133,482 5,069,657 7.96%
NOSH 1,064,965 1,064,965 1,064,965 1,065,111 1,064,783 1,065,037 1,065,054 -0.00%
Ratio Analysis
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
NP Margin 11.49% 10.09% 8.79% 16.75% 12.00% 8.11% 13.23% -
ROE 3.92% 2.92% 3.07% 5.88% 3.78% 2.20% 4.67% -
Per Share
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
RPS 275.51 209.92 246.41 222.36 178.56 135.07 177.98 7.55%
EPS 29.50 19.70 20.18 35.10 20.28 10.58 22.22 4.83%
DPS 15.00 15.00 15.00 15.00 15.00 10.00 15.00 0.00%
NAPS 7.54 6.75 6.58 5.97 5.36 4.82 4.76 7.96%
Adjusted Per Share Value based on latest NOSH - 1,065,111
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
RPS 260.19 198.25 232.71 210.02 168.60 127.57 168.09 7.54%
EPS 27.90 18.59 19.06 33.15 19.15 9.99 20.99 4.85%
DPS 14.17 14.17 14.17 14.17 14.16 9.44 14.17 0.00%
NAPS 7.1208 6.3747 6.2141 5.6388 5.0611 4.5523 4.4957 7.96%
Price Multiplier on Financial Quarter End Date
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Date 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 -
Price 24.20 20.92 24.60 21.20 16.68 10.60 16.20 -
P/RPS 8.78 9.97 9.98 9.53 9.34 7.85 9.10 -0.59%
P/EPS 81.92 106.26 121.90 60.40 82.25 100.19 72.91 1.96%
EY 1.22 0.94 0.82 1.66 1.22 1.00 1.37 -1.91%
DY 0.62 0.72 0.61 0.71 0.90 0.94 0.93 -6.53%
P/NAPS 3.21 3.10 3.74 3.55 3.11 2.20 3.40 -0.95%
Price Multiplier on Announcement Date
31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 CAGR
Date 21/05/14 22/05/13 24/05/12 25/05/11 26/05/10 27/05/09 21/05/08 -
Price 24.70 21.70 22.16 21.50 15.58 11.90 17.90 -
P/RPS 8.97 10.34 8.99 9.67 8.73 8.81 10.06 -1.89%
P/EPS 83.61 110.23 109.81 61.25 76.82 112.48 80.56 0.62%
EY 1.20 0.91 0.91 1.63 1.30 0.89 1.24 -0.54%
DY 0.61 0.69 0.68 0.70 0.96 0.84 0.84 -5.19%
P/NAPS 3.28 3.21 3.37 3.60 2.91 2.47 3.76 -2.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment